| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hair Follicle | 9 | 2015 | 29 | 1.730 |
Why?
|
| Epithelial Cells | 7 | 2014 | 391 | 1.050 |
Why?
|
| Skin Neoplasms | 7 | 2015 | 404 | 0.960 |
Why?
|
| Keratinocytes | 6 | 2015 | 63 | 0.860 |
Why?
|
| Stem Cells | 7 | 2015 | 255 | 0.830 |
Why?
|
| Skin | 4 | 2014 | 357 | 0.780 |
Why?
|
| Adult Stem Cells | 2 | 2011 | 28 | 0.710 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2014 | 289 | 0.710 |
Why?
|
| Melanoma | 3 | 2015 | 329 | 0.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2015 | 475 | 0.570 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 263 | 0.540 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 24 | 0.540 |
Why?
|
| Biomarkers, Tumor | 8 | 2018 | 461 | 0.540 |
Why?
|
| Multipotent Stem Cells | 2 | 2008 | 13 | 0.530 |
Why?
|
| Exome | 1 | 2016 | 73 | 0.530 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2014 | 237 | 0.530 |
Why?
|
| Precision Medicine | 2 | 2017 | 102 | 0.530 |
Why?
|
| Cell Movement | 5 | 2011 | 429 | 0.530 |
Why?
|
| Sebaceous Glands | 3 | 2011 | 6 | 0.520 |
Why?
|
| Databases, Genetic | 1 | 2016 | 83 | 0.520 |
Why?
|
| Alleles | 3 | 2016 | 411 | 0.510 |
Why?
|
| Cell Differentiation | 6 | 2014 | 1304 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 263 | 0.480 |
Why?
|
| Genome, Human | 1 | 2016 | 224 | 0.470 |
Why?
|
| Ribonuclease III | 2 | 2014 | 82 | 0.460 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 79 | 0.440 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2014 | 63 | 0.440 |
Why?
|
| Skin Diseases | 2 | 2011 | 76 | 0.420 |
Why?
|
| Alopecia | 2 | 2011 | 25 | 0.420 |
Why?
|
| Carcinogenesis | 1 | 2014 | 118 | 0.420 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 23 | 0.390 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 75 | 0.370 |
Why?
|
| Telepathology | 1 | 2011 | 6 | 0.370 |
Why?
|
| Melanocytes | 1 | 2012 | 78 | 0.370 |
Why?
|
| Stem Cell Niche | 1 | 2011 | 13 | 0.360 |
Why?
|
| Cicatrix | 1 | 2011 | 59 | 0.360 |
Why?
|
| Sebaceous Gland Neoplasms | 4 | 2014 | 10 | 0.350 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 179 | 0.350 |
Why?
|
| Dermatology | 1 | 2011 | 70 | 0.340 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 178 | 0.330 |
Why?
|
| beta Catenin | 4 | 2015 | 86 | 0.310 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 406 | 0.300 |
Why?
|
| Mice | 19 | 2017 | 10292 | 0.290 |
Why?
|
| Referral and Consultation | 1 | 2011 | 398 | 0.280 |
Why?
|
| Colonic Neoplasms | 4 | 2010 | 215 | 0.280 |
Why?
|
| Internet | 1 | 2011 | 448 | 0.280 |
Why?
|
| Humans | 39 | 2018 | 59360 | 0.260 |
Why?
|
| Wound Healing | 2 | 2006 | 174 | 0.250 |
Why?
|
| Animals | 21 | 2017 | 19651 | 0.240 |
Why?
|
| Dermis | 1 | 2004 | 16 | 0.230 |
Why?
|
| Hair | 3 | 2014 | 78 | 0.220 |
Why?
|
| Cell Line, Tumor | 9 | 2015 | 1370 | 0.210 |
Why?
|
| Immunohistochemistry | 8 | 2017 | 847 | 0.210 |
Why?
|
| Signal Transduction | 8 | 2017 | 2902 | 0.200 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2014 | 29 | 0.190 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 1118 | 0.190 |
Why?
|
| Materials Testing | 2 | 2012 | 82 | 0.180 |
Why?
|
| Cell Proliferation | 7 | 2014 | 942 | 0.180 |
Why?
|
| 3T3 Cells | 3 | 2014 | 108 | 0.170 |
Why?
|
| Adult | 13 | 2018 | 15669 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 339 | 0.170 |
Why?
|
| Stem Cell Transplantation | 2 | 2011 | 75 | 0.170 |
Why?
|
| T-Box Domain Proteins | 2 | 2014 | 39 | 0.170 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 234 | 0.160 |
Why?
|
| Female | 20 | 2018 | 30705 | 0.160 |
Why?
|
| Cell Adhesion | 2 | 2011 | 207 | 0.160 |
Why?
|
| Mice, SCID | 4 | 2014 | 513 | 0.160 |
Why?
|
| Mice, Inbred NOD | 4 | 2014 | 516 | 0.160 |
Why?
|
| Cellular Senescence | 2 | 2011 | 104 | 0.160 |
Why?
|
| Male | 17 | 2017 | 27739 | 0.150 |
Why?
|
| DNA Mismatch Repair | 3 | 2014 | 31 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 411 | 0.150 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2017 | 152 | 0.150 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 26 | 0.150 |
Why?
|
| Inflammation | 2 | 2017 | 1099 | 0.150 |
Why?
|
| Flow Cytometry | 2 | 2011 | 644 | 0.140 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 79 | 0.140 |
Why?
|
| Gene Amplification | 1 | 2017 | 23 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 394 | 0.140 |
Why?
|
| Japan | 1 | 2016 | 51 | 0.140 |
Why?
|
| Immunity | 1 | 2017 | 101 | 0.140 |
Why?
|
| Receptor, ErbB-2 | 1 | 2017 | 51 | 0.140 |
Why?
|
| Wnt Proteins | 2 | 2014 | 92 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2017 | 223 | 0.130 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2015 | 13 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 619 | 0.130 |
Why?
|
| Mammary Glands, Animal | 2 | 2014 | 78 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2014 | 616 | 0.120 |
Why?
|
| Middle Aged | 13 | 2018 | 16317 | 0.120 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 13 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 2 | 2015 | 196 | 0.120 |
Why?
|
| Apoptosis | 4 | 2014 | 1032 | 0.120 |
Why?
|
| Diagnosis, Differential | 4 | 2012 | 937 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2017 | 515 | 0.120 |
Why?
|
| DNA Damage | 2 | 2014 | 279 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2010 | 1151 | 0.110 |
Why?
|
| Keratins | 2 | 2004 | 30 | 0.110 |
Why?
|
| Fetus | 1 | 2014 | 93 | 0.110 |
Why?
|
| Trans-Activators | 2 | 2007 | 300 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2014 | 230 | 0.110 |
Why?
|
| Transplantation, Heterologous | 5 | 2014 | 223 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 53 | 0.110 |
Why?
|
| Fibroblasts | 3 | 2014 | 377 | 0.110 |
Why?
|
| ras Proteins | 1 | 2014 | 77 | 0.110 |
Why?
|
| Biomarkers | 3 | 2008 | 1306 | 0.110 |
Why?
|
| Integrin beta4 | 2 | 2011 | 31 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 277 | 0.100 |
Why?
|
| Breast | 1 | 2014 | 173 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2014 | 555 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2012 | 197 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 1206 | 0.100 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2012 | 31 | 0.100 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2012 | 30 | 0.100 |
Why?
|
| Tetraploidy | 1 | 2012 | 2 | 0.100 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2012 | 2 | 0.100 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2012 | 5 | 0.100 |
Why?
|
| Nevus | 1 | 2012 | 18 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 318 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2011 | 51 | 0.100 |
Why?
|
| False Positive Reactions | 1 | 2012 | 76 | 0.100 |
Why?
|
| Succinimides | 1 | 2011 | 17 | 0.100 |
Why?
|
| Neuropilin-2 | 1 | 2012 | 39 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 718 | 0.100 |
Why?
|
| Fluoresceins | 1 | 2011 | 29 | 0.100 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 17 | 0.100 |
Why?
|
| Subcutaneous Tissue | 1 | 2011 | 14 | 0.100 |
Why?
|
| Skin Ulcer | 1 | 2011 | 14 | 0.100 |
Why?
|
| Calciphylaxis | 1 | 2011 | 17 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2011 | 55 | 0.090 |
Why?
|
| Hemidesmosomes | 1 | 2011 | 6 | 0.090 |
Why?
|
| Prognosis | 5 | 2018 | 1600 | 0.090 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 98 | 0.090 |
Why?
|
| Adipocytes | 1 | 2014 | 255 | 0.090 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 5128 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2014 | 283 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 178 | 0.090 |
Why?
|
| Time-Lapse Imaging | 1 | 2011 | 18 | 0.090 |
Why?
|
| Skin Aging | 1 | 2011 | 9 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2010 | 332 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Adenoma | 2 | 2008 | 64 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2010 | 15 | 0.090 |
Why?
|
| Endothelium | 1 | 2010 | 18 | 0.090 |
Why?
|
| Cost Savings | 1 | 2011 | 52 | 0.090 |
Why?
|
| Workflow | 1 | 2011 | 63 | 0.090 |
Why?
|
| Barrett Esophagus | 1 | 2010 | 30 | 0.090 |
Why?
|
| Guanylate Cyclase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Methionine | 1 | 2010 | 53 | 0.090 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2010 | 27 | 0.090 |
Why?
|
| Aged | 10 | 2018 | 13416 | 0.090 |
Why?
|
| Receptors, Peptide | 1 | 2010 | 31 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 122 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 74 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 196 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2012 | 188 | 0.080 |
Why?
|
| Fluorescence | 1 | 2010 | 83 | 0.080 |
Why?
|
| Ischemia | 1 | 2011 | 199 | 0.080 |
Why?
|
| Carcinoma | 2 | 2008 | 115 | 0.080 |
Why?
|
| Sweat Gland Neoplasms | 2 | 2007 | 20 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2015 | 365 | 0.080 |
Why?
|
| Thrombosis | 1 | 2011 | 182 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 750 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2093 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1093 | 0.080 |
Why?
|
| fas Receptor | 1 | 2009 | 55 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 161 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 452 | 0.080 |
Why?
|
| Coculture Techniques | 2 | 2009 | 95 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 141 | 0.080 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 25 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2012 | 2374 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 70 | 0.080 |
Why?
|
| Phenotype | 4 | 2017 | 1137 | 0.080 |
Why?
|
| Mutation | 3 | 2017 | 2456 | 0.080 |
Why?
|
| Epidermis | 1 | 2008 | 35 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 323 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2017 | 1994 | 0.070 |
Why?
|
| Neoplasms, Adnexal and Skin Appendage | 1 | 2007 | 1 | 0.070 |
Why?
|
| Eccrine Glands | 1 | 2007 | 3 | 0.070 |
Why?
|
| Carcinoma, Ductal | 1 | 2007 | 3 | 0.070 |
Why?
|
| Stromal Cells | 3 | 2014 | 65 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 96 | 0.070 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2007 | 30 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 243 | 0.070 |
Why?
|
| Hypotrichosis | 1 | 2006 | 4 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2012 | 1782 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 148 | 0.070 |
Why?
|
| Time Factors | 2 | 2011 | 3617 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 277 | 0.070 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2006 | 10 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 95 | 0.070 |
Why?
|
| Lipase | 1 | 2006 | 48 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 194 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2017 | 6071 | 0.060 |
Why?
|
| Integrin alpha6beta4 | 1 | 2005 | 44 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 868 | 0.060 |
Why?
|
| Regeneration | 1 | 2006 | 93 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 55 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 234 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 631 | 0.060 |
Why?
|
| Young Adult | 2 | 2012 | 4267 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2018 | 300 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2012 | 3067 | 0.060 |
Why?
|
| Keratins, Type II | 1 | 2004 | 1 | 0.060 |
Why?
|
| Left-Right Determination Factors | 1 | 2004 | 3 | 0.060 |
Why?
|
| Keratins, Hair-Specific | 1 | 2004 | 2 | 0.060 |
Why?
|
| Necrosis | 2 | 2017 | 140 | 0.060 |
Why?
|
| Retroviridae | 1 | 2004 | 69 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2005 | 382 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 170 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 294 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 196 | 0.050 |
Why?
|
| Foot Deformities, Congenital | 1 | 2002 | 2 | 0.050 |
Why?
|
| Tail | 1 | 2002 | 6 | 0.050 |
Why?
|
| Biopsy | 2 | 2017 | 411 | 0.050 |
Why?
|
| Fetal Proteins | 1 | 2002 | 8 | 0.050 |
Why?
|
| Child | 1 | 2012 | 4174 | 0.050 |
Why?
|
| Fibroadenoma | 1 | 2002 | 3 | 0.050 |
Why?
|
| Cystadenoma | 1 | 2002 | 6 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 730 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 51 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2015 | 258 | 0.050 |
Why?
|
| Eyelid Neoplasms | 1 | 2002 | 9 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 674 | 0.050 |
Why?
|
| Cell Line | 3 | 2015 | 1984 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 1025 | 0.050 |
Why?
|
| Adolescent | 1 | 2012 | 5824 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 857 | 0.050 |
Why?
|
| Genetic Markers | 3 | 2006 | 116 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 651 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 710 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2010 | 3231 | 0.040 |
Why?
|
| Lipid Metabolism | 2 | 2014 | 203 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 79 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2018 | 59 | 0.040 |
Why?
|
| Lymphadenopathy | 1 | 2017 | 22 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 355 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2050 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 1552 | 0.040 |
Why?
|
| Fibrosis | 1 | 2017 | 153 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2017 | 202 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 172 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 188 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 188 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2008 | 293 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 5284 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2015 | 17 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 426 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 844 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2015 | 6 | 0.030 |
Why?
|
| Testosterone | 1 | 2015 | 112 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 194 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2015 | 49 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 550 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 75 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 71 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 228 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 63 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2014 | 24 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 115 | 0.030 |
Why?
|
| Estrogens | 1 | 2014 | 109 | 0.030 |
Why?
|
| Progesterone | 1 | 2014 | 158 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 912 | 0.030 |
Why?
|
| Base Sequence | 2 | 2006 | 1302 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 396 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 55 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2010 | 850 | 0.030 |
Why?
|
| Lactation | 1 | 2014 | 66 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 411 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 191 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 676 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 137 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1554 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1952 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1465 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1561 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2014 | 173 | 0.020 |
Why?
|
| Arterioles | 1 | 2011 | 7 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 83 | 0.020 |
Why?
|
| Capillaries | 1 | 2011 | 30 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 340 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 127 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 116 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2011 | 25 | 0.020 |
Why?
|
| Serine | 1 | 2011 | 83 | 0.020 |
Why?
|
| Drug Stability | 1 | 2011 | 141 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 287 | 0.020 |
Why?
|
| Metaplasia | 1 | 2010 | 18 | 0.020 |
Why?
|
| Genes, APC | 1 | 2010 | 9 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2010 | 48 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 48 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 250 | 0.020 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 1 | 2010 | 3 | 0.020 |
Why?
|
| Receptors, Enterotoxin | 1 | 2010 | 3 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2010 | 32 | 0.020 |
Why?
|
| Epithelium | 1 | 2010 | 96 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 65 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 244 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 45 | 0.020 |
Why?
|
| Phagocytes | 1 | 2010 | 50 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 297 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 146 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 145 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 78 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 118 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 43 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 172 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2010 | 177 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 39 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 221 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 343 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 527 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 590 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 884 | 0.020 |
Why?
|
| Back | 1 | 2008 | 4 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 450 | 0.020 |
Why?
|
| Keratoacanthoma | 1 | 2008 | 2 | 0.020 |
Why?
|
| Thorax | 1 | 2008 | 34 | 0.020 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2008 | 1 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 207 | 0.020 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Extremities | 1 | 2008 | 46 | 0.020 |
Why?
|
| Abdomen | 1 | 2008 | 91 | 0.020 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2007 | 5 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2009 | 196 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2008 | 75 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 156 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 588 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 675 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 107 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 109 | 0.020 |
Why?
|
| Lod Score | 1 | 2006 | 23 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 26 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Russia | 1 | 2006 | 53 | 0.020 |
Why?
|
| Alu Elements | 1 | 2006 | 9 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2008 | 259 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2202 | 0.020 |
Why?
|
| Retroelements | 1 | 2006 | 39 | 0.020 |
Why?
|
| Homozygote | 1 | 2006 | 114 | 0.020 |
Why?
|
| Pedigree | 1 | 2006 | 183 | 0.020 |
Why?
|
| Heterozygote | 1 | 2006 | 161 | 0.020 |
Why?
|
| Luciferases | 1 | 2006 | 106 | 0.020 |
Why?
|
| Exons | 1 | 2006 | 191 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 603 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 170 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 356 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 241 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 238 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 657 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 4984 | 0.010 |
Why?
|
| Keratin-15 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 559 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 809 | 0.010 |
Why?
|
| Syndactyly | 1 | 2002 | 1 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1122 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 38 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 46 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2002 | 41 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 105 | 0.010 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 26 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 55 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2002 | 49 | 0.010 |
Why?
|
| Hindlimb | 1 | 2002 | 44 | 0.010 |
Why?
|
| Hidrocystoma | 1 | 2002 | 1 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2002 | 29 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 443 | 0.010 |
Why?
|
| Cysts | 1 | 2002 | 40 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 806 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 617 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2007 | 1471 | 0.010 |
Why?
|